Private Capital Group’s Moderna MRNA Stock Holding History

Private Capital Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$52K	Sell	364 -78	-18%	-$11.1K	0.04%	470
2022 Q1	$76K	Buy	442 +60	+16%	+$10.1K	0.02%	491
2021 Q4	$97K	Sell	382 -21	-5%	-$6.14K	0.02%	437
2021 Q3	$155K	Buy	403 +93	+30%	+$34.3K	0.03%	286
2021 Q2	$73K	Buy	310 +45	+17%	+$8.04K	0.02%	526
2021 Q1	$35K	Buy	265 +254	+2,309%	+$36.8K	0.01%	789
2020 Q4	$1K	Buy	11 +2	+22%	+$202	﹤0.01%	1920
2020 Q3	$1K	Sell	9 -62	-87%	-$4.32K	﹤0.01%	1865
2020 Q2	$5K	Buy	+71	New	+$3.89K	﹤0.01%	1521

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Capital Group's MRNA Position: Q2 2022 in Review

Private Capital Group reduced its Moderna (MRNA) stake by 18% in Q2 2022, selling an estimated $11.1K and leaving 364 shares worth $52K. The position accounts for 0.04% of the portfolio, ranked #470.

Private Capital Group first reported a position in MRNA in Q2 2020 and has held it in 9 quarters since. The position peaked at $155K in Q3 2021. 982 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

Private Capital Group held 364 shares of Moderna worth $52K as of Q2 2022.
Private Capital Group sold 78 Moderna shares in Q2 2022, an estimated $11.1K.
Moderna made up 0.04% of Private Capital Group's portfolio in Q2 2022, its #470 holding.
Private Capital Group first reported a position in Moderna in Q2 2020 and has held it in 9 quarters since.
Private Capital Group's Moderna position peaked at $155K in Q3 2021.
982 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.